Abstract |
The emergence of fluconazole-resistant Candida (FRC) is worrisome, but little is known about susceptibility patterns in different nosocomial settings. We prospectively analysed Candida bloodstream isolates in 18 medical centres in Israel (six tertiary-care and 12 community hospitals). The study included 444 episodes of candidaemia (450 patient-specific isolates, 8.5% fluconazole-resistant). Institutional FRC bloodstream infection rates correlated with annual inpatient days, and were strongly associated with the presence and activity of haematology/oncology services. Infection with Candida krusei and fluconazole-resistant Candida glabrata occurred exclusively in hospitals with >600 beds. These findings suggest that empirical antifungal strategies should be tailored to the nosocomial setting.
|
Authors | R Ben-Ami, G Rahav, H Elinav, I Kassis, I Shalit, T Gottesman, O Megged, M Weinberger, P Ciobotaro, P Shitrit, G Weber, A Paz, D Miron, I Oren, J Bishara, C Block, N Keller, D P Kontoyiannis, M Giladi, Israeli Candidaemia Study Group |
Journal | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
(Clin Microbiol Infect)
Vol. 19
Issue 8
Pg. 752-6
(Aug 2013)
ISSN: 1469-0691 [Electronic] England |
PMID | 23005038
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases. |
Chemical References |
- Antifungal Agents
- Fluconazole
|
Topics |
- Adult
- Aged
- Antifungal Agents
(pharmacology)
- Candida
(drug effects, isolation & purification)
- Candida glabrata
- Candidemia
(epidemiology)
- Cross Infection
(epidemiology)
- Drug Resistance, Fungal
- Female
- Fluconazole
(pharmacology)
- Hospitals
- Humans
- Israel
(epidemiology)
- Male
- Middle Aged
- Prevalence
- Prospective Studies
|